Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Oraxol in Subjects With Cutaneous Angiosarcoma

NCT03544567 is registered in ClinicalTrials.gov with Athenex, Inc. as lead sponsor.

NCT NCT03544567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03544567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Oraxol in Subjects With Cutaneous Angiosarcoma
Lead sponsor
Athenex, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 21, 2018
Completion date
May 12, 2023
Enrollment
48 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

angiosarcoma of skin